Jensterle M - Search Results

1

Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience.

Kocjan T, Jensterle M, Vidmar G, Vrckovnik R, Berden P, Stankovic M. Kocjan T, et al. Among authors: jensterle m. Radiol Oncol. 2020 Aug 5;54(4):409-418. doi: 10.2478/raon-2020-0052. Radiol Oncol. 2020. PMID: 32889797 Free PMC article.

2

Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series.

Jensterle M, Janez A, Vrtovec B, Meden-Vrtovec H, Pfeifer M, Prezelj J, Kocjan T. Jensterle M, et al. Croat Med J. 2007 Dec;48(6):864-70. doi: 10.3325/cmj.2007.6.864. Croat Med J. 2007. PMID: 18074422 Free PMC article.

3

Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome.

Jensterle M, Sebestjen M, Janez A, Prezelj J, Kocjan T, Keber I, Pfeifer M. Jensterle M, et al. Eur J Endocrinol. 2008 Oct;159(4):399-406. doi: 10.1530/EJE-08-0507. Epub 2008 Jul 24. Eur J Endocrinol. 2008. PMID: 18653546 Clinical Trial.

4

Dihydrotachysterol intoxication treated with pamidronate: a case report.

Jensterle M, Pfeifer M, Sever M, Kocjan T. Jensterle M, et al. Cases J. 2010 Mar 26;3:78. doi: 10.1186/1757-1626-3-78. Cases J. 2010. PMID: 20507648 Free PMC article.

5

Phosphodiesterase 4 inhibition as a potential new therapeutic target in obese women with polycystic ovary syndrome.

Jensterle M, Kocjan T, Janez A. Jensterle M, et al. J Clin Endocrinol Metab. 2014 Aug;99(8):E1476-81. doi: 10.1210/jc.2014-1430. Epub 2014 May 13. J Clin Endocrinol Metab. 2014. PMID: 24823465 Clinical Trial.

6

Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.

Jensterle M, Kocjan T, Kravos NA, Pfeifer M, Janez A. Jensterle M, et al. Endocr Res. 2015;40(3):133-8. doi: 10.3109/07435800.2014.966385. Epub 2014 Oct 20. Endocr Res. 2015. PMID: 25330463 Clinical Trial.

7

A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.

Jensterle M, Kravos NA, Pfeifer M, Kocjan T, Janez A. Jensterle M, et al. Hormones (Athens). 2015 Jan-Mar;14(1):81-90. doi: 10.1007/BF03401383. Hormones (Athens). 2015. PMID: 25885106 Free article. Clinical Trial.

8

Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study.

Jensterle M, Salamun V, Kocjan T, Vrtacnik Bokal E, Janez A. Jensterle M, et al. J Ovarian Res. 2015 Jun 2;8:32. doi: 10.1186/s13048-015-0161-3. J Ovarian Res. 2015. PMID: 26032655 Free PMC article. Clinical Trial.

9

A NEW CLINICAL PREDICTION CRITERION ACCURATELY DETERMINES A SUBSET OF PATIENTS WITH BILATERAL PRIMARY ALDOSTERONISM BEFORE ADRENAL VENOUS SAMPLING.

Kocjan T, Janez A, Stankovic M, Vidmar G, Jensterle M. Kocjan T, et al. Among authors: jensterle m. Endocr Pract. 2016 May;22(5):587-94. doi: 10.4158/EP15982.OR. Epub 2016 Jan 20. Endocr Pract. 2016. PMID: 26789347

10

Advances in the management of craniopharyngioma in children and adults.

Jensterle M, Jazbinsek S, Bosnjak R, Popovic M, Zaletel LZ, Vesnaver TV, Kotnik BF, Kotnik P. Jensterle M, et al. Radiol Oncol. 2019 Oct 25;53(4):388-396. doi: 10.2478/raon-2019-0036. Radiol Oncol. 2019. PMID: 31652121 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters